Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma
Authors
Keywords
-
Journal
Pigment Cell & Melanoma Research
Volume 28, Issue 6, Pages 718-729
Publisher
Wiley
Online
2015-09-11
DOI
10.1111/pcmr.12420
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
- (2015) Deepak Sampath et al. PHARMACOLOGY & THERAPEUTICS
- Visfatin promotes cell and tumor growth by upregulating Notch1 in breast cancer
- (2015) Hyun-Joo Park et al. Oncotarget
- Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia
- (2014) Valentina Audrito et al. BLOOD
- Visfatin contributes to the differentiation of monocytes into macrophages through the differential regulation of inflammatory cytokines in THP-1 cells
- (2014) Mi Ran Yun et al. CELLULAR SIGNALLING
- Nicotinamide Phosphoribosyltransferase Promotes Epithelial-to-Mesenchymal Transition as a Soluble Factor Independent of Its Enzymatic Activity
- (2014) Debora Soncini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors
- (2013) Ubaldina Galli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells
- (2013) Tania Romacho et al. PLoS One
- Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling
- (2012) Vinodkumar B. Pillai et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Extracellular ATP induces P2X7-dependent nicotinamide phosphoribosyltransferase release in LPS-activated human monocytes
- (2012) Erik Schilling et al. Innate Immunity
- Visfatin induces stromal cell-derived factor-1 expression by β1 integrin signaling in colorectal cancer cells
- (2012) Wen-Shih Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions
- (2012) Elena Maldi et al. Pigment Cell & Melanoma Research
- Melanoma-derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signature
- (2012) Tao Wang et al. Pigment Cell & Melanoma Research
- The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool
- (2011) Andrew D. Revell et al. AIDS
- Possible Role of Visfatin in Hepatoma Progression and the Effects of Branched-Chain Amino Acids on Visfatin-Induced Proliferation in Human Hepatoma Cells
- (2011) S. Ninomiya et al. Cancer Prevention Research
- Unknown
- (2011) Michal Kukla et al. MOLECULAR MEDICINE
- Visfatin Induces Sickness Responses in the Brain
- (2011) Byong Seo Park et al. PLoS One
- Nicotinamide Phosphoribosyltransferase/Visfatin Does Not Catalyze Nicotinamide Mononucleotide Formation in Blood Plasma
- (2011) Nobumasa Hara et al. PLoS One
- PBEF1/NAmPRTase/Visfatin: A potential malignant astrocytoma/glioblastoma serum marker with prognostic value
- (2010) P. Sreekanth Reddy et al. CANCER BIOLOGY & THERAPY
- Effects of Visfatin on Proliferation and Collagen Synthesis in Rat Cardiac Fibroblasts
- (2010) X-Y. Yu et al. HORMONE AND METABOLIC RESEARCH
- Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study
- (2010) Shunsaku Takahashi et al. Journal of Translational Medicine
- Visfatin stimulates proliferation of MCF-7 human breast cancer cells
- (2010) Jae Geun Kim et al. MOLECULES AND CELLS
- Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes
- (2009) A. Garten et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
- (2009) Anne von Heideman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Nicotinamide Phosphoribosyltransferase: A Molecular Link between Metabolism, Inflammation, and Cancer
- (2009) M. Galli et al. CANCER RESEARCH
- Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity
- (2009) T. Romacho et al. DIABETOLOGIA
- Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-κB pathway
- (2009) W-J Lee et al. INTERNATIONAL JOURNAL OF OBESITY
- NAMPT is essential for the G-CSF–induced myeloid differentiation via a NAD+–sirtuin-1–dependent pathway
- (2009) Julia Skokowa et al. NATURE MEDICINE
- A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis
- (2009) Snehal T. Patel et al. PEPTIDES
- Essential Role of Pre–B-Cell Colony Enhancing Factor in Ventilator-induced Lung Injury
- (2008) Sang-Bum Hong et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Visfatin Stimulates Production of Monocyte Chemotactic Protein-1 and Interleukin-6 in Human Vein Umbilical Endothelial Cells
- (2008) S. Liu et al. HORMONE AND METABOLIC RESEARCH
- Characterization of NAD Uptake in Mammalian Cells
- (2008) Richard A. Billington et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signaling Mechanism
- (2008) Yankun Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nampt: linking NAD biology, metabolism and cancer
- (2008) Antje Garten et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More